198 related articles for article (PubMed ID: 25966467)
1. A method for human teratogen detection by geometrically confined cell differentiation and migration.
Xing J; Toh YC; Xu S; Yu H
Sci Rep; 2015 May; 5():10038. PubMed ID: 25966467
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Micropatterned Human Pluripotent Stem Cell Test (µP-hPST) for Morphometric-Based Teratogen Screening.
Xing J; Cao Y; Yu Y; Li H; Song Z; Yu H
Sci Rep; 2017 Aug; 7(1):8491. PubMed ID: 28819231
[TBL] [Abstract][Full Text] [Related]
3. Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells.
Mayshar Y; Yanuka O; Benvenisty N
J Cell Mol Med; 2011 Jun; 15(6):1393-401. PubMed ID: 20561110
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a teratogenic transcriptome-based predictive test based on human embryonic versus inducible pluripotent stem cells.
Shinde V; Perumal Srinivasan S; Henry M; Rotshteyn T; Hescheler J; Rahnenführer J; Grinberg M; Meisig J; Blüthgen N; Waldmann T; Leist M; Hengstler JG; Sachinidis A
Stem Cell Res Ther; 2016 Dec; 7(1):190. PubMed ID: 28038682
[TBL] [Abstract][Full Text] [Related]
5. Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.
Nishi M; Akutsu H; Kudoh A; Kimura H; Yamamoto N; Umezawa A; Lee SW; Ryo A
Oncotarget; 2014 Sep; 5(18):8665-80. PubMed ID: 25228591
[TBL] [Abstract][Full Text] [Related]
6. Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies.
Konala VBR; Nandakumar S; Surendran H; Datar S; Bhonde R; Pal R
Toxicol Appl Pharmacol; 2021 Dec; 433():115792. PubMed ID: 34742744
[TBL] [Abstract][Full Text] [Related]
7. Teratogen screening with human pluripotent stem cells.
Worley KE; Rico-Varela J; Ho D; Wan LQ
Integr Biol (Camb); 2018 Sep; 10(9):491-501. PubMed ID: 30095839
[TBL] [Abstract][Full Text] [Related]
8. Full biological characterization of human pluripotent stem cells will open the door to translational research.
Kramer N; Rosner M; Kovacic B; Hengstschläger M
Arch Toxicol; 2016 Sep; 90(9):2173-2186. PubMed ID: 27325309
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide induces apoptosis during early mesodermal differentiation of human induced pluripotent stem cells.
Tachikawa S; Shimizu M; Maruyama K; Ohnuma K
In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):231-240. PubMed ID: 29435726
[TBL] [Abstract][Full Text] [Related]
10. A novel human stem cell-based biomarker assay for in vitro assessment of developmental toxicity.
Jamalpoor A; Hartvelt S; Dimopoulou M; Zwetsloot T; Brandsma I; Racz PI; Osterlund T; Hendriks G
Birth Defects Res; 2022 Nov; 114(19):1210-1228. PubMed ID: 35289129
[TBL] [Abstract][Full Text] [Related]
11. In vitro uses of human pluripotent stem cell-derived cardiomyocytes.
Matsa E; Denning C
J Cardiovasc Transl Res; 2012 Oct; 5(5):581-92. PubMed ID: 22639342
[TBL] [Abstract][Full Text] [Related]
12. Editor's Highlight: Identification and Characterization of Teratogenic Chemicals Using Embryonic Stem Cells Isolated From a Wnt/β-Catenin-Reporter Transgenic Mouse Line.
Kugler J; Kemler R; Luch A; Oelgeschläger M
Toxicol Sci; 2016 Aug; 152(2):382-94. PubMed ID: 27208078
[TBL] [Abstract][Full Text] [Related]
13. High-throughput identification of small molecules that affect human embryonic vascular development.
Vazão H; Rosa S; Barata T; Costa R; Pitrez PR; Honório I; de Vries MR; Papatsenko D; Benedito R; Saris D; Khademhosseini A; Quax PH; Pereira CF; Mercader N; Fernandes H; Ferreira L
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3022-E3031. PubMed ID: 28348206
[TBL] [Abstract][Full Text] [Related]
14. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.
Chen YS; Pelekanos RA; Ellis RL; Horne R; Wolvetang EJ; Fisk NM
Stem Cells Transl Med; 2012 Feb; 1(2):83-95. PubMed ID: 23197756
[TBL] [Abstract][Full Text] [Related]
15. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
16. Teratogenic potential in cultures optimized for oligodendrocyte development from mouse embryonic stem cells.
Sadowski D; Kiel ME; Apicella M; Arriola AG; Chen CP; McKinnon RD
Stem Cells Dev; 2010 Sep; 19(9):1343-53. PubMed ID: 20131970
[TBL] [Abstract][Full Text] [Related]
17. P19 neuronal differentiation and retinoic acid metabolism as criteria to investigate atrazine, nitrite, and nitrate developmental toxicity.
Solari M; Paquin J; Ducharme P; Boily M
Toxicol Sci; 2010 Jan; 113(1):116-26. PubMed ID: 19808863
[TBL] [Abstract][Full Text] [Related]
18. BMP4 promotes EMT and mesodermal commitment in human embryonic stem cells via SLUG and MSX2.
Richter A; Valdimarsdottir L; Hrafnkelsdottir HE; Runarsson JF; Omarsdottir AR; Ward-van Oostwaard D; Mummery C; Valdimarsdottir G
Stem Cells; 2014 Mar; 32(3):636-48. PubMed ID: 24549638
[TBL] [Abstract][Full Text] [Related]
19. Teratogenic Rubella Virus Alters the Endodermal Differentiation Capacity of Human Induced Pluripotent Stem Cells.
Bilz NC; Willscher E; Binder H; Böhnke J; Stanifer ML; Hübner D; Boulant S; Liebert UG; Claus C
Cells; 2019 Aug; 8(8):. PubMed ID: 31405163
[TBL] [Abstract][Full Text] [Related]
20. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
